-
From Bharathi Vennapusa on November 22nd, 2020
0 likes 1 playsDr. Michael Lynch of Medical and Scientific Affairs for Roche Diagnostics reviews 3 cases that show the borderline tissue staining of IC around 1% of tumor area that a… -
From Bharathi Vennapusa on November 22nd, 2020
0 likes 2 playsDr. Michael Lynch of Medical and Scientific Affairs for Roche Diagnostics reviews 3 cases that show the most common pattern of tissue staining a pathologist will see in… -
From Bharathi Vennapusa on November 22nd, 2020
0 likes 2 playsDr. Michael Lynch of Medical and Scientific Affairs for Roche Diagnostics reviews 3 cases that show the most common tissue staining pattern a pathologist will see in the… -
From Bharathi Vennapusa on November 22nd, 2020
0 likes 1 playsVENTANA PD-L1 (SP142) assay is the first and only FDA-approved assay for mTNBC*. Testing for PD-L1 identifies patients who could benefit from TECENTRIQ + nab-pac in… -
From Bharathi Vennapusa on November 22nd, 2020
0 likes 1 playsVENTANA PD-L1 (SP142) IHC assay is FDA-approved for mTNBC. Test for PD-L1 to identify patients who could benefit from TECENTRIQ + nab-pac in 1L mTNBC* This video is… -
From Bharathi Vennapusa on November 22nd, 2020
0 likes 1 playsUS Pathologist, Dr. Michael Lynch, from the Medical and Scientific Affairs (MSA) department for Roche Tissue Diagnostics discusses: 1. SP142 assay is optimized for… -
From Bharathi Vennapusa on November 22nd, 2020
0 likes 2 playsUS Pathologist, Dr. Michael Lynch, from the Medical and Scientific Affairs (MSA) department for Roche Tissue Diagnostics discusses on: 1. The PD-L1 biomarker and its… -
From Bharathi Vennapusa on November 22nd, 2020
0 likes 1 playsUS Pathologist, Dr. Michael Lynch, from the Medical and Scientific Affairs (MSA) department for Roche Tissue Diagnostics discusses: 1. How and why PD-L1 is present on… -
From Bharathi Vennapusa on November 22nd, 2020
0 likes 1 playsUS Pathologist, Dr. Michael Lynch, from the Medical and Scientific Affairs (MSA) department for Roche Tissue Diagnostics discusses the tumor microenvironment, the cancer… -
From Bharathi Vennapusa on November 20th, 2020
0 likes 2 playsDr. Katie Robertson from Roche MSA discusses testing algorithms for NTRK fusion testing. Content and approvals of any product related info is current as of the date of… -
From Bharathi Vennapusa on November 20th, 2020
0 likes 3 playsDr. Bharathi Vennapusa from Roche MSA reviews example cases stained with VENTANA pan-TRK (EPR17341) Assay using digital slides. Content and approvals of any product… -
From Bharathi Vennapusa on November 20th, 2020
0 likes 1 playsDr. Denise Croix from Roche MSA discusses NTRK fusions biology and testing methods. Content and approvals of any product related info is current as of the date of… -
From Bharathi Vennapusa on November 20th, 2020
0 likes 1 playsDr. Bharathi Vennapusa from Roche MSA discusses 2018 CAP/ASCO HER2 guideline update and how it pertains to Roche HER2 Assays. Content and approvals of any product… -
From Bharathi Vennapusa on November 20th, 2020
0 likes 2 playsDr. Bharathi Vennapusa from Roche MSA discusses Pan-TRK IHC using VENTANA pan-TRK (EPR17341) Assay. Content and approvals of any product related info is current as of… -
From Bharathi Vennapusa on November 20th, 2020
0 likes 0 playsThis episode is part 2 in a series on the PD-L1 (SP142) assay in non small cell lung cancer. In this episode, Roche Tissue Diagnostics Medical and Scientific Affairs…
Search for ""
Public, Restricted and Moderated
- Managers:
- Appears in: